. the software identified and measured a marker of svd and then gave a score indicating how severe the disease was ranging from mild to severe..
in a news release, the drug's manufacturer, amgen, said the list price will be 5 a month or ,900 annually. costs to patients may vary depending on insurance..
"it's a very exciting time," klugman said. "this is exactly where we would like prenatal diagnosis to go -- to be able to act on it.".
johns hopkins all children's hospital. [jim damaske |times]